Overview

Neurochemical Mechanisms of the Awake vs. Anesthetized Brain

Status:
Recruiting
Trial end date:
2023-04-01
Target enrollment:
Participant gender:
Summary
The investigators will be studying the sedative drug dexmedetomidine using hybrid PET/fMRI/EEG imaging to better understand the neuropharmacology of anesthesia/artificially induced sleep.
Phase:
Early Phase 1
Details
Lead Sponsor:
Massachusetts General Hospital
Collaborator:
Boston University
Treatments:
Dexmedetomidine